CNTB
Connect Biopharma Holdings LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$132.82M
P/E Ratio
—
EPS
$-1.15
Beta
-0.18
52W High
$3.82
52W Low
$0.73
50-Day MA
$2.68
200-Day MA
$2.30
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.77
PEG Ratio
—
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China.
Fundamentals
| Revenue (TTM) | 233,000 |
| Gross Profit (TTM) | 233,000 |
| EBITDA | $-65.54M |
| Operating Margin | -11602.00% |
| Return on Equity | -102.90% |
| Return on Assets | -54.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.68 |
| Price-to-Book | 3.10 |
| Price-to-Sales (TTM) | 570.06 |
| EV/Revenue | 373.04 |
| EV/EBITDA | 0.19 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $56.52M |
| Float | $13.40M |
| % Insiders | 33.63% |
| % Institutions | 54.26% |
Historical Volatility
HV 10-Day
103.98%
HV 20-Day
79.00%
HV 30-Day
73.64%
HV 60-Day
87.97%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($7.25 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026